We are live on
!
Find out more
EMR
Errol M. Rudman Portfolio holdings
AUM
$148M
Turnover
10%
1-Year Est. Return
19.65%
This Fund
S&P 500
This Quarter
Est. Return
+6.11%
1 Year Est. Return
+19.65%
3 Year Est. Return
+60.53%
5 Year Est. Return
+120.34%
10 Year Est. Return
–
AUM
$296M
AUM Growth
+$7.52M
(+2.6%)
Cap. Flow
-$2.5M
Cap. Flow
% of AUM
-0.84%
Top 10 Holdings %
Top 10 Hldgs %
46.87%
Holding
45
New
2
Increased
6
Reduced
5
Closed
1
Avg Time Held
1.2
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBPO
China Biologic Products Holdings, Inc.
CBPO
|
+$2.1M |
| 2 |
Patterson Companies, Inc.
PDCO
|
+$1.43M |
| 3 |
ManpowerGroup
MAN
|
+$1.12M |
| 4 |
VCA Inc.
WOOF
|
+$1.06M |
| 5 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$1.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PTX
Pernix Therapeutics Holdings, Inc.
PTX
|
+$3.99M |
| 2 |
MSO
MARTHA STEWART LIVING OMNIMEDIA INC
MSO
|
+$3.74M |
| 3 |
La-Z-Boy
LZB
|
+$1.35M |
| 4 |
CO
Global Cord Blood Corporation
CO
|
+$878K |
| 5 |
Bruker
BRKR
|
+$808K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.59% |
| 2 | Industrials | 25.27% |
| 3 | Financials | 9.83% |
| 4 | Technology | 9.29% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
TransDigm Group
TDG
$62.5B
| $18.8M | 6.36% |
83,895
| – | – |
2013 Q2
8 quarters
|
|
|
LVLT
2
DELISTED
Level 3 Communications Inc
LVLT
| $17.4M | 5.87% |
329,867
| – | – |
2014 Q4
2 quarters
|
|
3
Community Health Systems
CYH
$420M
| $16.1M | 5.42% |
308,550
| – | – |
2014 Q1
5 quarters
|
|
|
CBPO
4
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $15M | 5.06% |
130,201
+20,000
| +18% | +$2.1M |
2014 Q2
4 quarters
|
|
5
AMN Healthcare
AMN
$1.51B
| $12.8M | 4.32% |
405,200
| – | – |
2014 Q2
4 quarters
|
|
6
Mohawk Industries
MHK
$8.41B
| $12.6M | 4.26% |
66,025
| – | – |
2013 Q2
8 quarters
|
|
7
United Airlines
UAL
$32.6B
| $12.1M | 4.08% |
227,900
-300
| -0.1% | -$17.4K |
2013 Q2
8 quarters
|
|
8
Bank of America
BAC
$362B
| $12M | 4.05% |
704,800
| – | – |
2014 Q3
3 quarters
|
|
9
Delta Air Lines
DAL
$51B
| $11.4M | 3.83% |
276,410
| – | – |
2013 Q2
8 quarters
|
|
|
ESRX
10
DELISTED
Express Scripts Holding Company
ESRX
| $10.7M | 3.61% |
120,226
| – | – |
2013 Q2
8 quarters
|
|
11
DELISTED
Cross Country Healthcare
CCRN
| $10.2M | 3.43% |
801,513
+18,204
| +2% | +$206K |
2014 Q2
4 quarters
|
|
|
SIRO
12
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
| $9.96M | 3.36% |
99,200
| – | – |
2013 Q2
8 quarters
|
|
13
Thermo Fisher Scientific
TMO
$258B
| $9.34M | 3.15% |
72,000
| – | – |
2013 Q4
6 quarters
|
|
14
HCA Healthcare
HCA
$102B
| $9.18M | 3.1% |
101,200
| – | – |
2013 Q2
8 quarters
|
|
15
Lazard
LAZ
$3.52B
| $8.45M | 2.85% |
150,176
| – | – |
2013 Q2
8 quarters
|
|
|
16
DELISTED
VCA Inc.
WOOF
| $8.35M | 2.82% |
153,500
+20,000
| +15% | +$1.06M |
2014 Q2
4 quarters
|
|
17
CVS Health
CVS
$118B
| $8.28M | 2.79% |
78,904
| – | – |
2013 Q2
8 quarters
|
|
18
IBM
IBM
$219B
| $8.13M | 2.75% |
52,300
| – | – |
2014 Q4
2 quarters
|
|
19
DELISTED
Anywhere Real Estate
HOUS
| $7.47M | 2.52% |
160,000
| – | – |
2014 Q4
2 quarters
|
|
20
RB Global
RBA
$16.2B
| $6.59M | 2.22% |
235,950
| – | – |
2014 Q1
5 quarters
|
|
21
BlackBerry
BB
$4.97B
| $6.26M | 2.11% |
765,000
| – | – |
2014 Q1
5 quarters
|
|
|
CVC
22
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
| $6.2M | 2.09% |
258,960
| – | – |
2013 Q2
8 quarters
|
|
23
Tenet Healthcare
THC
$22.2B
| $5.79M | 1.95% |
100,000
| – | – |
2013 Q4
6 quarters
|
|
24
Sensata Technologies
ST
$5.89B
| $5.44M | 1.84% |
103,160
| – | – |
2013 Q2
8 quarters
|
|
25
Palo Alto Networks
PANW
$302B
| $5.24M | 1.77% |
180,000
| – | – |
2015 Q1
1 quarter
|
|
Similar funds
HAM
TAM
RMPT
QAM
CWM
RCA
CI
LS
Errol M. Rudman's Q2 2015 Portfolio in Review
As of Q2 2015, Errol M. Rudman held 45 positions worth $296M, up 2.6% from $289M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Errol M. Rudman's Q2 2015 filing shows 2 new, 6 increased, 5 reduced and 1 closed positions. Its largest new stake was Patterson Companies, Inc.: 30,000 shares worth $1.46M. The largest sale was Pernix Therapeutics Holdings, Inc., an estimated $3.99M.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Industrials and Financials.
- Errol M. Rudman's largest Q2 2015 buy was Patterson Companies, Inc.: 30,000 shares worth $1.46M.
- Errol M. Rudman added most to China Biologic Products Holdings, Inc. in Q2 2015, an estimated $2.1M increase.
- Errol M. Rudman's biggest Q2 2015 reduction was Pernix Therapeutics Holdings, Inc., cutting an estimated $3.99M.
- Errol M. Rudman fully exited Global Cord Blood Corporation in Q2 2015, selling an estimated $878K.
- Errol M. Rudman's ten largest holdings make up 47% of its $296M portfolio in Q2 2015.
- Errol M. Rudman opened 2 new positions and closed 1 in Q2 2015.
- Errol M. Rudman's portfolio value rose 2.6% quarter-over-quarter to $296M.
Based on Errol M. Rudman's 13F filing for Q2 2015, filed 14 Aug 2015.